Pirouz, Mehdi https://orcid.org/0000-0002-7439-6066
Wang, Chih-Hao https://orcid.org/0000-0003-1704-1311
Liu, Qi
Ebrahimi, Aref G.
Shamsi, Farnaz https://orcid.org/0000-0003-3506-6950
Tseng, Yu-Hua https://orcid.org/0000-0003-2053-9559
Gregory, Richard I. https://orcid.org/0000-0001-8090-8673
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (K01DK121861)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM086386)
Article History
Received: 19 August 2019
Accepted: 30 April 2020
First Online: 26 May 2020
Competing interests
: R.I.G. is co-founder and scientific advisory board member of 28-7 Therapeutics. The remaining authors declare no competing interests.